Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 51 (KRT18P51) is one of many processed pseudogenes derived from the type I keratin 18 (KRT18) gene, dispersed throughout the human genome. These pseudogenes do not encode an intact protein and are considered nonfunctional[3][5]. They are distinct from the functional KRT18 gene, which encodes an intermediate filament protein involved in epithelial cell structure and is a biomarker for several cancers, but pseudogenes such as KRT18P51 have no confirmed biological function, role in disease, or involvement with drugs. KRT18P51 should not be confused with the protein-coding KRT18 gene.
None (pseudogene; no mechanism of drug action)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 51 (KRT18P51).